Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies
about
End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals.HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.
P2860
Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence of end of treatment ...... fosbuvir combination therapies
@en
Prevalence of end of treatment ...... osbuvir combination therapies.
@nl
type
label
Prevalence of end of treatment ...... fosbuvir combination therapies
@en
Prevalence of end of treatment ...... osbuvir combination therapies.
@nl
prefLabel
Prevalence of end of treatment ...... fosbuvir combination therapies
@en
Prevalence of end of treatment ...... osbuvir combination therapies.
@nl
P2093
P2860
P356
P1476
Prevalence of end of treatment ...... fosbuvir combination therapies
@en
P2093
Harel Dahari
Miguel Malespin
Scott J Cotler
Susan L Uprichard
Tamara Benyashvili
P2860
P356
10.1177/1756283X16672392
P577
2016-10-17T00:00:00Z